Skip to main content
OpenTrials
Completed

NCT Number: NCT00831883

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

About this study

Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • English-speaking ability
  • unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
  • marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
  • sentence or placement length between 2 and 12 months
  • must plan to remain in the area for the 6 months following their release from the facility
  • must be willing to provide two pieces of contact information for follow-up

Exclusion criteria

  • signs of psychosis (assessed through clinical assessment)

Treatment and study plan

Partner-Specific IMB-based HIV risk reduction intervention

Behavioral

5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.

Healthy lifestyle

Behavioral

5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Primary outcomes

  1. lower levels of sex-related HIV risk behavior

    Time frame: 3 months

Secondary outcomes

  1. knowledge about STI transmission

    Time frame: 3 months

  2. partner-specific perceptions of STI risks

    Time frame: 3 months

  3. social norms, expectations and personal attitudes regarding partner-specific sexual behavior

    Time frame: 3 months

  4. partner-specific behavioral and communication skills

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Women and Infants Hospital of Rhode Island

Other

Collaborators

  • University of Rhode Island

Registry information

Official study title

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Incarcerated Adolescents

Acronym: GET UP

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jan 29, 2009
Registry last updated
Dec 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.